Certara Corporation Updates Its Simcyp Simulator Used To Predict Drug Behavior In Virtual Patient Populations

PRINCETON, N.J.--(BUSINESS WIRE)--Certara®, the leading global technology-enabled drug development and drug safety consultancy, today announced that it has released version 14 of its Simcyp™ Population-based Simulator, which enables biopharmaceutical researchers to predict drug-drug interactions and pharmacokinetic-pharmacodynamic (PK-PD) outcomes in virtual human and animal populations.

Help employers find you! Check out all the jobs and post your resume.